Loading
Life sciences · Journal article
Egyptian Liver Journal · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Background Metabolic dysfunction-associated fatty liver disease (MASLD) is closely linked to obesity, altered body composition, and metabolic dysregulation. The creatinine-to-body weight (Cre/BW) ratio has been proposed as a simple surrogate measure of relative muscle mass and metabolic risk. This study aimed to evaluate the association between the Cre/BW ratio and metabolic dysfunction, HSI-defined steatosis, and hepatic indices, and to assess its diagnostic performance in non-elderly Egyptian patients. Methods This cross-sectional study included 190 non-elderly patients who underwent clinical, biochemical, and imaging assessments. The creatinine-to-body weight (Cre/BW) ratio was calculated and evaluated in relation to anthropometric measures, liver enzymes, Hepatic Steatosis Index (HSI), and fibroscan parameters. ROC analysis was performed using HSI ≥36 as a surrogate definition of metabolic steatosis. Results A lower creatinine-to-body weight ratio was significantly associated with higher HSI (r = −0.260, p < 0.001), BMI (r = −0.263, p < 0.001), and waist circumference (r = −0.225, p = 0.002). The ratio showed stronger associations with metabolic and obesity-related parameters than with imaging-based measures of hepatic steatosis or fibrosis severity. Conclusion A low creatinine-to-body weight ratio was associated with metabolic dysfunction and HSI-defined steatosis in non-elderly Egyptian patients. However, this association was not independently maintained after adjustment for BMI and other metabolic factors, suggesting that the Cre/BW ratio may primarily reflect body composition and obesity-related metabolic abnormalities rather than serving as an independent marker of hepatic steatosis.